Results 31 to 40 of about 3,050,532 (174)
A case for newborn screening for pyridoxine-dependent epilepsy. [PDF]
Pyridoxine dependent epilepsy due to mutations in ALDH7A1 (PDH-ALDH7A1) is a highly treatable developmental and epileptic encephalopathy. Pharmacologic doses of pyridoxine are associated with dramatic clinical seizure improvement and most patient achieve adequate seizure control with pyridoxine alone.
Coughlin CR +2 more
europepmc +5 more sources
Late diagnosis of pyridoxine-dependent epilepsy in two adolescent siblings [PDF]
Sedat Işıkay
doaj +2 more sources
Phenotypic Variability of Pyridoxine-Dependent Epilepsy
Pyridoxine-dependent epilepsy (PDE) is a rare autosomal recessive disorder characterized by seizures in neonates or infants, which is unresponsive to antiepileptic drugs but controlled by pyridoxine.
ERÇAL, MURAT DERYA +2 more
openaire +2 more sources
Association Between Lysine Reduction Therapies and Cognitive Outcomes in Patients With Pyridoxine-Dependent Epilepsy. [PDF]
BACKGROUND AND OBJECTIVES: Pyridoxine-dependent epilepsy (PDE-ALDH7A1) is a developmental epileptic encephalopathy characterized by seizure improvement after pyridoxine supplementation. Adjunct lysine reduction therapies (LRTs) reduce the accumulation of
Coughlin CR +23 more
europepmc +2 more sources
Treatable cause of refractory seizures in an infant with a novel mutation
Pyridoxine-dependent epilepsy is a treatable cause of epilepsy, which is very well known. It is most commonly caused by mutations in ALDH7A1 and PNPO genes. A 5-month-old infant presented with refractory seizures.
Ruchi R Mittal +2 more
doaj +1 more source
Copy number variations (CNVs) have been related to developmental and epileptic encephalopathy (DEE). The 2q24.3 region includes a cluster of genes for voltage-gated sodium channels (SCN) and CNVs in this region cause DEE. However, the long-term course of
Takuya Masuda +8 more
doaj +1 more source
Feasibility of newborn screening for pyridoxine-dependent epilepsy. [PDF]
Pyridoxine-dependent epilepsy (PDE-ALDH7A1) is a developmental epileptic encephalopathy historically characterized by seizures that are resistant to antiseizure medications. Treatment with pyridoxine and lysine reduction therapies are associated with seizure control and improved developmental outcomes. In rare circumstances, patients have died prior to
Pauly K +9 more
europepmc +3 more sources
Callosal alterations in pyridoxine‐dependent epilepsy [PDF]
AimWhile there have been isolated reports of callosal morphology differences in pyridoxine‐dependent epilepsy (PDE), a rare autosomal disorder caused by ALDH7A1 gene mutations, no study has systematically evaluated callosal features in a large sample of patients.
Friedman, S.D. +9 more
openaire +3 more sources
The Genotypic Spectrum of ALDH7A1 Mutations Resulting in Pyridoxine Dependent Epilepsy: A Common Epileptic Encephalopathy [PDF]
Michael A Swanson +2 more
exaly +2 more sources
Epilepsia por dependência de piridoxina: um relato de caso
Pyridoxine-dependent epilepsy (EDP) is an autosomal recessive disease clinically represented by recurrent seizures. The diagnosis is made by clinical observation, and may be assisted by electroencephalography (EEG) and biochemical and genetic tests.
Larissa Magalhães de Paiva +5 more
doaj +1 more source

